Vir Biotechnology, Inc. (VIR)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-05) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-06) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-23) · 99.1 · 99.2 · 99.3 | 8-K (2026-01-12) · 99.1 · 99.2 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-05) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-06) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-07) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-26) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-10-31) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-01) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-02) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-22) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Comprehensive Income (loss) | — |
|
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Comprehensive (loss) Income | ||
| Consolidated Statements of Stockholders Equity | ||
| Condensed Consolidated Statements of Stockholders' Equity (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Acquisitions | — |
|
| Balance Sheet Components | ||
| Collaboration and License Agreements | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Defined Contribution Plan | — |
|
| Fair Value Measurements | ||
| Goodwill and Intangible Assets | — |
|
| Grant Agreements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | — |
|
| Net (loss) Income Per Share | ||
| Net Income (loss) Per Share | — |
|
| Net Loss Per Share | ||
| Organization | ||
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | ||
| Restructuring and Related Activities | — |
|
| Restructuring, Asset Impairment and Related Charges | — |
|
| Restructuring, Impairment and Other Costs | — |
|
| Restructuring, Impairment and Related Costs | — |
|
| Segment Reporting | ||
| Stock-based Awards | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | ||